CN114478589A - Phenanthroline compound, organic electroluminescent device and display or lighting device - Google Patents

Phenanthroline compound, organic electroluminescent device and display or lighting device Download PDF

Info

Publication number
CN114478589A
CN114478589A CN202210229776.5A CN202210229776A CN114478589A CN 114478589 A CN114478589 A CN 114478589A CN 202210229776 A CN202210229776 A CN 202210229776A CN 114478589 A CN114478589 A CN 114478589A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
organic electroluminescent
charge generation
electroluminescent device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210229776.5A
Other languages
Chinese (zh)
Inventor
高春吉
赵晓宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uiv Chem Yurui Shanghai Chemical Co ltd
Zhejiang Huadisplay Optoelectronics Co Ltd
Original Assignee
Uiv Chem Yurui Shanghai Chemical Co ltd
Zhejiang Huadisplay Optoelectronics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uiv Chem Yurui Shanghai Chemical Co ltd, Zhejiang Huadisplay Optoelectronics Co Ltd filed Critical Uiv Chem Yurui Shanghai Chemical Co ltd
Priority to CN202210229776.5A priority Critical patent/CN114478589A/en
Publication of CN114478589A publication Critical patent/CN114478589A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention provides a phenanthroline compound, an organic electroluminescent device, and a display or lighting device, the phenanthroline compound being represented by formula 1 below:
Figure DDA0003540084650000011
wherein Ar is1And Ar2Each independently selected from substituted or unsubstituted C12-C30 phenanthroline derivative groups; ar (Ar)3And Ar4Each independently selected from hydrogen, deuterium, halogen, C6-C30 aryl or C5-C30 heteroaryl, wherein at least one is C12-C30 aryl or C12-C30 heteroaryl; l is pyridyl, pyrimidinyl, pyrazinyl or imidazolyl. The organic electroluminescent device containing the phenanthroline compound is formed between an n-type charge generation layer and a p-type charge generation layerThe energy level difference is minimized, and the electron injection amount of the light emitting part is increased, thereby reducing the driving voltage and improving the efficiency.

Description

Phenanthroline compound, organic electroluminescent device and display or lighting device
Technical Field
The present invention relates to a phenanthroline compound, and more particularly, to a phenanthroline compound and an organic electroluminescent device including the same.
Background
A light emitting device is a device that converts electric energy into light energy using an organic substance, and includes a structure of an organic layer that is possible to emit light between an anode and a cathode.
The organic light emitting device may be formed in various structures, and among them, an organic light emitting device in which a plurality of light emitting cells are overlapped (tentem) is being studied.
In the overlap (tentem) type organic electroluminescent device, light emitting cells including a light emitting layer are stacked between an anode and a cathode.
There is a charge generation layer between adjacent light emitting portions for generation and movement of charges.
The charge generation layer requires a low driving voltage and high efficiency.
Disclosure of Invention
The present invention provides an organic electroluminescent device comprising a phenanthroline compound, minimizing an energy level difference between an n-type charge generation layer and a p-type charge generation layer, and increasing an electron injection amount of a light emitting part, thereby reducing a driving voltage and improving current efficiency.
In order to realize the purpose of the invention, the technical scheme of the invention is as follows:
the invention provides a phenanthroline compound, and the structure of the phenanthroline compound is shown as a formula 1
Figure BDA0003540084630000011
Wherein Ar is1And Ar2Each independently selected from substituted or unsubstituted C12-C30 phenanthroline derivative groups;
Ar3and Ar4Each independently selected from hydrogen, deuterium, halogen, C6-C30 aryl or C5-C30 heteroaryl, wherein at least one is C12-C30 aryl or C12-C30 heteroaryl;
l is pyridyl, pyrimidinyl, pyrazinyl or imidazolyl.
Preferably, wherein the phenanthroline compound is represented by any one of formulae 1-1 to 1-5 below:
Figure BDA0003540084630000021
wherein R is1To R16Each independently selected from substituted or unsubstituted hydrogen, deuterium, halogen, alkyl, C6-C30 aryl, and C5-C30 heteroaryl;
Ar3and Ar4Each independently selected from hydrogen, deuterium, halogen, C6-C30 aryl or C5-C30 heteroaryl, wherein at least one is C12-C30 aryl or C12-C30 heteroaryl;
X1is carbon or nitrogen.
Preferably, wherein R1To R16Each independently selected from substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthracenyl, substituted or unsubstituted phenanthryl, substituted or unsubstituted pyrenyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidyl, substituted or unsubstituted pyrazinyl, substituted or unsubstituted benzimidazolyl, substituted or unsubstituted indolyl, substituted or unsubstituted quinolyl, substituted or unsubstituted isoquinolyl, substituted or unsubstituted phenanthrolinyl, substituted or unsubstituted naphthyridinyl, or combinations thereof.
Preferably, wherein the phenanthroline compound represented by formula 1-1 is represented by the following formula 2-1 to formula 2-3:
Figure BDA0003540084630000022
wherein R is2—R16Each independently selected from substituted or unsubstituted hydrogen, deuterium, halogen, alkyl, C6-C30 aryl, and C5-C30 heteroaryl;
X1and X2Selected from carbon or nitrogen.
More preferably, wherein the phenanthroline compound is any one of:
Figure BDA0003540084630000031
Figure BDA0003540084630000041
Figure BDA0003540084630000051
Figure BDA0003540084630000061
the present invention also provides an organic electroluminescent device, comprising:
a first electrode;
a second electrode; and
an organic layer between the first electrode and the second electrode;
the organic layer includes the phenanthroline compound of the present invention.
Preferably wherein at least one of the organic layers is a charge generation layer or an electron transport layer.
More preferably, the charge generation layer is an n-type charge generation layer.
More preferably, the n-type charge generation layer is composed of a metal or an organic material doped with an n-type, wherein the metal is selected from Li, Na, K, Rb, Cs, Mg, Ca, Sr, Ba, La, Ce, Sm, Eu, Tb, Dy, or Yb.
The present invention also provides an organic electroluminescent device, comprising:
a first electrode;
a second electrode;
a first light-emitting portion of a first light-emitting layer located between the first electrode and the second electrode;
a second light emitting portion of a second light emitting layer located between the second electrode and the first light emitting portion; and
a first charge generation layer located between the first light-emitting portion and the second light-emitting portion;
at least one of the first light-emitting portion, the second light-emitting portion, or the first charge generation layer includes a phenanthroline compound of the present invention.
The invention also provides an application of the o-phenanthroline compound in the preparation of organic electroluminescent devices.
The invention further provides a display or lighting device comprising the organic electroluminescent device of the invention.
According to the present invention, in the case where the n-type charge generation layer is doped with a basic metal, the alkali metal minimizes the diffusion of the alkali metal into the p-type charge generation layer in order to firmly permeate into the main compound of phenanthroline compound, thereby using the organic electroluminescent device.
Provided are an o-phenanthroline compound capable of improving a lifetime, and an organic light-emitting element including the same.
Drawings
Fig. 1 is a structural layer diagram of an organic electroluminescent device according to the present invention.
Detailed Description
An object of the present invention is to provide an o-phenanthroline compound capable of improving an electron injection amount for a light emitting portion by minimizing an energy level difference between an n-type charge generation layer and a p-type charge generation layer, and an organic electroluminescent device including the same.
It is another object of the present invention to provide a phenanthroline compound and an organic electroluminescent device comprising the same, which can minimize the diffusion of alkali metal into a p-type charge generation layer even when an n-type charge generation layer is doped with alkali metal.
According to the present invention, in the case where the n-type charge generation layer is doped with a basic metal, the alkali metal minimizes the diffusion of the alkali metal into the p-type charge generation layer in order to firmly permeate into the main compound, o-phenanthroline compound, thereby improving the lifetime of the organic light emitting device.
Provided are a phenanthroline compound capable of improving the lifetime of a device and an organic electroluminescent device comprising the same.
The phenanthroline compound shown in formula 1 contains more than four nitrogen atoms, and is represented by formula R1-R16The aromatic compound and the heteroaryl are introduced to enrich the electrons of the nitrogen atomAnd therefore faster electron mobility, facilitates electron transport. In addition, the N-type charge generation layer (N-CGL) contains nitrogen of sp2 hybrid orbital, which combines with a metal doped as the N-type charge generation layer to form a gap state (Gapstate). Therefore, electrons can be smoothly transferred from the P-type charge generation layer (P-CGL) to the N-type charge generation layer (N-CGL) through the gap state. The N-type charge generation layer may be composed of a metal selected from Li, Na, K, Rb, Cs, Mg, Ca, Sr, Ba, La, Ce, Sm, Eu, Tb, Dy, or Yb, or an N-type doped organic material.
Further, by introducing various substituents into the above core structure, a compound having inherent properties of the introduced substituents can be synthesized. For example, a hole injection layer material and a hole transport layer material used for manufacturing an organic light emitting device are a compound that transports holes along the highest energy level orbital (HOMO) and a compound that blocks electrons that cross from the light emitting layer along the lowest energy level orbital (LUMO).
In particular, the core structure of the compound has stable characteristics with respect to electrons, and can improve the device lifetime. It is possible to prepare materials for the electron transport layer and the hole blocking material having an appropriate energy band gap.
In addition, by introducing various substituents into the core structure, the energy band gap can be finely adjusted, and at the same time, the interfacial properties between organic materials are improved, so that the use of the materials is diversified.
The charge generation layer (CG) includes a P-type charge generation layer (CGP) and an N-type charge generation layer (CGN), is located between a first light emitting part including a first hole transport layer, a first light emitting layer, and a first electron transport layer, and a second light emitting part including a second hole transport layer, a second light emitting layer, and a second electron transport layer in this order, and is composed of a PN connection structure connecting the first light emitting part and the second light emitting part.
That is, the above-described first electron transport layer has a PN junction structure above, and provides a charge generation layer including a P-type charge generation layer (CGP) and an N-type charge generation layer (CGN), and the above-described N-type charge generation layer material may use the phenanthroline compound represented by formula 1 according to the present invention. Here, the N-type charge generation layer supplies electrons to the first electron transport layer of the first light emitting portion, the first electron transport layer supplies electrons to the first light emitting layer, the P-type charge generation layer supplies holes to the second hole transport layer of the second light emitting portion, and the second hole transport layer supplies holes to the second light emitting layer.
Here, for the first light-emitting layer of the first light-emitting part; and a second light emitting layer of the second light emitting part, each of which may include the same or different host and the same or different dopant. In addition, in the organic light emitting device according to the embodiment of the present invention, the hole injection layer (30) is positioned between the anode (20) and the first hole transport layer (40-1), and the second electron transport layer (60-2) is positioned between the electron injection layer (70) and the second light emitting layer (50-2).
The organic electroluminescent device may have various variations, for example, a part of the organic layer may be omitted or added, may not be an overlapping structure, and may be an overlap of 2 or more than 4 light emitting layers. In addition, the organic light emitting device may include an electron transport layer and an electron injection layer, in which case the electron transport layer and the electron injection layer may use the phenanthroline compound of the present invention.
The method for preparing the organic electroluminescent device of the present invention is not particularly limited, and may be prepared by using a method and materials for preparing a light emitting device, which are well known to those skilled in the art, in addition to the phenanthroline compound represented by formula 1.
Examples
Example 1: synthesis of Compound 1
1) Synthesis of intermediate 1-1-2
Figure BDA0003540084630000091
To a three-necked flask were added 2, 6-dibromo-4-chloropyridine (21.7g,80mmol), the compound 1-1-1(19.7g,88mmol), triphenylphosphine (6 mol%), bis (triphenylphosphine) palladium (II) dichloride (2.1g, 3 mol%), potassium phenoxide (16.1g,121.9mmol) and anhydrous toluene (300mL) under nitrogen protection. After the nitrogen substitution, the reaction was stirred at 50 ℃ for 5 hours, and then the system was cooled to room temperature and quenched by adding water. The reaction mixture was extracted with benzene solvent and saturated brine. The organic phase was dried over anhydrous magnesium sulfate. The dried mixture was filtered and concentrated under reduced pressure, and purification by column chromatography or distillation gave intermediate 1-1-2(9.19g, yield 31%). LC-MS: M/Z368.97(M +)
2) Synthesis of Compound 1-1-3
Figure BDA0003540084630000092
1-1-2(29.7g,80mmol), compound 1-1-1(19.7g,88mmol), triphenylphosphine (6 mol%), bis (triphenylphosphine) palladium (II) dichloride (2.1g, 3 mol%), potassium phenoxide (16.1g,121.9mmol) and dry toluene (300mL) were added to a three-necked flask under nitrogen protection. After the nitrogen substitution, the reaction was stirred at 50 ℃ for 5 hours, and then the system was cooled to room temperature and quenched by adding water. The reaction mixture was extracted with benzene solvent and saturated brine. The organic phase was dried over anhydrous magnesium sulfate. The dried mixture was filtered and concentrated under reduced pressure, and purification by column chromatography or distillation gave intermediate 1-1-3(16.2g, yield 43%). LC-MS: M/Z469.11(M +)
3) Synthesis of Compound 1-1
Figure BDA0003540084630000093
After the compound 1-1-3(14.6g, 31mmol) was dissolved in 1, 4-dioxane (130mL), the compound 1-1-4(7.11g, 32mmol), palladium tetrakistriphenylphosphine (1.8g, 1.5mmol) and potassium carbonate (12.8 g, 93mmol) were added thereto, and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and then filtered and concentrated. The concentrated residue was purified by column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compound 1-1(11.34g, yield 60%). LC-MS: M/Z609.22(M +).
Example 2: synthesis of Compounds 1-4
Figure BDA0003540084630000101
After the compound 1-1-3(14.6g, 31mmol) was dissolved in 1, 4-dioxane (130mL), the compound 1-4-1(7.17g, 32mmol), palladium tetrakistriphenylphosphine (1.8g, 1.5mmol) and potassium carbonate (12.8 g, 93mmol) were added thereto, and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and then filtered and concentrated. The concentrated residue was purified by column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compounds 1-4(10.62g, yield 56%). LC-MS: M/Z613.20(M +).
Example 3: synthesis of Compounds 1-16
Figure BDA0003540084630000102
Synthesis of Compounds 1 to 16 by reference to the Synthesis methods of Compounds 1 to 4 in example 2, Compound 1 to 16 was obtained ((11.37g, yield 48%). LC-MS: M/Z763.27(M +).
Example 4: synthesis of Compounds 1-20
Figure BDA0003540084630000111
1) Synthesis of intermediate 1-20-1
After the compound 1-1-1(3.36g, 15mmol) was dissolved in 1, 4-dioxane (130mL), 2, 6-dibromo-3, 5-dichloropyridine (4.43g, 14.5mmol), Pd (PPh) and the like were added thereto3)4(0.18g, 0.15mmol) and K2CO3(12.8 g, 93mmol), and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was MgSO4Dried, and then filtered and concentrated. Purifying the concentrated residue by column chromatography using ethyl acetate and hexane as developing agents to obtainThe objective Compound 1-20-1(1.88g, yield 32%). LC-MS: M/Z402.93(M +).
2) Synthesis of intermediate 1-20-2
After dissolving Compound 1-1-1(3.36g, 15mmol) in 1, 4-dioxane (130mL), 1-20-1(5.87g, 14.5mmol), Pd (PPh) were added thereto3)4(0.18g, 0.15mmol) and K2CO3(12.8 g, 93mmol), and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was MgSO4Dried, and then filtered and concentrated. The concentrated residue was purified by column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compound 1-20-2(3.35g, yield 46%). LC-MS: M/Z501.08(M +).
3) Synthesis of intermediates 1-20-3
After the compound phenylboronic acid (1.83g, 15mmol) was dissolved in 1, 4-dioxane (130mL), 1-20-2(7.28g, 14.5mmol), Pd (PPh) were added thereto3)4(0.18g, 0.15mmol) and K2CO3(12.8 g, 93mmol), and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was MgSO4Dried, and then filtered and concentrated. The concentrated residue was purified by column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compound 1-20-3(4.37g, yield 51%). LC-MS: M/Z545.14(M +).
4) Synthesis of intermediates 1 to 20
After the compound 1-1-4(3.33g, 15mmol) was dissolved in 1, 4-dioxane (130mL), 1-20-3(7.92g, 14.5mmol), Pd (PPh) were added thereto3)4(0.18g, 0.15mmol) and K2CO3(12.8 g, 93mmol), and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was MgSO4Dried, and then filtered and concentrated. Purifying the concentrated residue with column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compound 1-20(6.28g, yield 63%). LC-MS: M/Z687.24(M +).
Example 5: synthesis of Compounds 1-26
Figure BDA0003540084630000121
1) Synthesis of intermediate 26-2
1-1-2(29.65g,80mmol),1-26-1(26.41g,88mmol), triphenylphosphine (6 mol%), bis (triphenylphosphine) palladium (II) dichloride (2.1g, 3 mol%), potassium phenoxide (16.1g,121.9mmol) and dry toluene (500mL) were added to a three-necked flask under nitrogen protection. After the nitrogen substitution, the reaction was stirred at 50 ℃ for 5 hours, and then the system was cooled to room temperature and quenched by adding water. The reaction mixture was extracted with a benzene solvent and saturated brine. The organic phase was dried over anhydrous magnesium sulfate. The dried mixture was filtered and concentrated under reduced pressure, and purification by column chromatography or distillation gave intermediate 1-26-2(23.59g, yield 54%). LC-MS: M/Z545.14(M +).
2) Synthesis of Compounds 1-26
After dissolving the compound 1-26-2(16.93g, 31mmol) in 1, 4-dioxane (500mL), 1-26-3(7.14g, 32mmol), palladium tetrakistriphenylphosphine (1.8g, 1.5mmol) and potassium carbonate (12.8 g, 93mmol) were added thereto, and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, and then filtered and concentrated. The concentrated residue was purified using column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compounds 1 to 26(13.0g, yield 61%). LC-MS: M/Z687.24(M +).
Example 6: synthesis of Compounds 1-43
Figure BDA0003540084630000122
1) Synthesis of intermediates 1-43-2
In the presence of 1-43-1(3.36g, 15mmol) in 1, 4-dioxane (200mL)Then, 3, 5-dibromo-2-chloropyrazine (3.95g, 14.5mmol), Pd (PPh3)4(0.18g, 0.15mmol) and K were added thereto2CO3(12.8 g, 93mmol), and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was dried over MgSO4, and then filtered and concentrated. The concentrated residue was purified by column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compound 1-43-2(1.82g, yield 34%). LC-MS: M/Z366.95(M +).
2) Synthesis of intermediates 1-43-3
After dissolving compound 1-1-1(3.36g, 15mmol) in 1, 4-dioxane (200mL), 1-43-2(5.34g, 14.5mmol), Pd (PPh3)4(0.18g, 0.15mmol) and K were added thereto2CO3(12.8 g, 93mmol), and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was MgSO4Dried, and then filtered and concentrated. The concentrated residue was purified by column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compound 1-43-3(2.59g, yield 38%). LC-MS: M/Z469.11(M +).
3) Synthesis of Compounds 1-43
After dissolving compound 1-1-4(3.33g, 15mmol) in 1, 4-dioxane (200mL), 1-43-3(6.81g, 14.5mmol), Pd (PPh3)4(0.18g, 0.15mmol) and K were added thereto2CO3(12.8 g, 93mmol), and the resultant was stirred at 100 ℃ for 6 hours. After the reaction was terminated, the resultant was cooled to room temperature and extracted with distilled water and ethyl acetate. The organic layer was MgSO4Dried, and then filtered and concentrated. The concentrated residue was purified by column chromatography using ethyl acetate and hexane as developing agents to obtain the objective compounds 1 to 43(5.77g, yield 65%). LC-MS: M/Z611.21(M +).
Example 7: synthesis of Compounds 1-71
Figure BDA0003540084630000131
After dissolving compound 1-71-2(11.94g,25.0mmol) and compound 1-71-1(7.95g,32.0mmol) in ethanol, potassium hydroxide (4.2g,76mmol) was added, and after stirring at room temperature for 3 hours, the precipitated solid was washed with methanol to obtain the objective compound 1-71(5.17g, yield 30%). LC-MS: M/Z589.23(M +).
Example 8: synthesis of Compounds 1-96
Synthesis of Compound 1-96 with reference to the Synthesis method of Compound 1-1 in example 1, Compound 1-96 was obtained ((12.65g, yield 55%). LC-MS: M/Z741.26(M +).
Device embodiments
As shown in fig. 1, the organic light emitting device according to an embodiment of the present invention includes an anode (20), a first hole transport layer (40-1), a first light emitting layer (50-1) including a host and a dopant, a first light emitting unit including a first electron transport layer (60-1), a charge generation layer (CG) including a P-type charge generation layer (CGP) and an N-type charge generation layer (CGN), and a second light emitting unit including a second hole transport layer (40-2), a second light emitting layer (50-2) including a host and a dopant, a second electron transport layer (60-2) and a cathode (80).
The layers of the organic electroluminescent element of the present invention can be formed by vacuum evaporation, sputtering, ion plating, or the like, or by wet film formation such as spin coating, printing, or the like, and the solvent used is not particularly limited.
< Experimental example 1> production of organic light-emitting device
1. First embodiment
Manufacturing of organic electroluminescent device:
the ITO glass substrate was patterned to have a light-emitting area of 3mm × 3 mm. The patterned ITO glass substrate was then washed, and then placed in a vacuum chamber with a standard pressure set at 1X 10-6And (4) supporting. Thereafter, HATCN was vapor-deposited on the ITO substrate to a thickness of
Figure BDA0003540084630000141
The first Hole Injection Layer (HIL) is formed by depositing HTL-1 on the first hole injection layer to a thickness of
Figure BDA0003540084630000142
The Hole Transport Layer (HTL) of (1), CBP + RD-1(3 wt%) is vapor-deposited on the hole transport layer to a thickness of
Figure BDA0003540084630000143
With Alq3 (thickness
Figure BDA0003540084630000144
) In the compound 1-1 represented by the formula 1, Yb (2%) is doped and evaporated to have a thickness of
Figure BDA0003540084630000145
The thickness of the N-type charge generation layer and the HATCN is
Figure BDA0003540084630000146
Then, HTL-1 is evaporated to form a layer having a thickness of
Figure BDA0003540084630000147
Is deposited with BH + BD (3 wt%) to a thickness of
Figure BDA0003540084630000148
A second electron transport layer (thickness: Alq 3) formed by vapor deposition
Figure BDA0003540084630000149
) Depositing LiF (thickness of
Figure BDA00035400846300001410
) Al (thickness)
Figure BDA00035400846300001411
) Thereby manufacturing an organic electroluminescent device.
Figure BDA00035400846300001412
Figure BDA0003540084630000151
2. Second embodiment
An organic electroluminescent device of the second embodiment was fabricated by the same method as the first embodiment described above, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced with the compound 1-4 from the compound 1-1 of the first embodiment.
3. Third embodiment
An organic electroluminescent device of the third embodiment was fabricated by the same method as that of the first embodiment described above, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced with the compound 1-16 from the compound 1-1 of the first embodiment.
4. Fourth embodiment
An organic electroluminescent device of the fourth embodiment was fabricated by the same method as that of the first embodiment described above, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced with the compound 1-20 from the compound 1-1 of the first embodiment.
5. Fifth embodiment
An organic electroluminescent device of the fifth embodiment was fabricated by the same method as that of the first embodiment described above, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced with the compound 1-26 from the compound 1-1 of the first embodiment.
6. Sixth embodiment
An organic electroluminescent device according to the sixth embodiment was fabricated by the same method as that of the first embodiment described above, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced with the compound 1-43 from the compound 1-1 according to the first embodiment.
7. Seventh embodiment
An organic electroluminescent device according to the seventh embodiment was fabricated by the same method as that of the above-described first embodiment, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced with the compound 1-71 instead of the compound 1-1 according to the first embodiment.
8. Eighth embodiment
An organic electroluminescent device according to the seventh embodiment was fabricated by the same method as that of the above-described first embodiment, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced with the compound 1-96 from the compound 1-1 according to the first embodiment.
9. Comparative example 1
The organic electroluminescent device of comparative example 1 was prepared in the same manner as in the first embodiment described above, except that the N-type charge generation layer (N-CGL) of the organic electroluminescent device was replaced from the compound 1-1 of the first embodiment to the compound Ref-1.
The organic electroluminescent device was fabricated using standard methods known in the art at 10mA/cm2Voltage and efficiency were tested under current conditions.
Table 1 shows the performance test results of the organic electroluminescent devices prepared in the examples and comparative examples of the present invention.
TABLE 1
Figure BDA0003540084630000152
Figure BDA0003540084630000161
As shown in table 1, the organic electroluminescent device including the specific compound according to the present disclosure as a CGL material has a reduced driving voltage and improved current efficiency compared to a comparative organic electroluminescent device.
The foregoing has described the general principles, principal features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are given by way of illustration of the principles of the present invention, and that various changes and modifications may be made without departing from the spirit and scope of the invention as defined by the appended claims. The scope of the invention is defined by the appended claims and equivalents thereof.

Claims (12)

1. The structure of the phenanthroline compound is shown as a formula 1:
Figure FDA0003540084620000011
wherein Ar is1And Ar2Each independently selected from substituted or unsubstituted C12-C30 phenanthroline derivative groups;
Ar3and Ar4Each independently selected from hydrogen, deuterium, halogen, C6-C30 aryl or C5-C30 heteroaryl, wherein at least one is C12-C30 aryl or C12-C30 heteroaryl;
l is pyridyl, pyrimidinyl, pyrazinyl or imidazolyl.
2. The phenanthroline compound according to claim 1, wherein the phenanthroline compound is represented by any one of formulae 1-1 to 1-5 below:
Figure FDA0003540084620000012
wherein R is1To R16Each independently selected from substituted or unsubstituted hydrogen, deuterium, halogen, alkyl, C6-C30 aryl, and C5-C30 heteroaryl;
Ar3and Ar4Each independently selected from hydrogen, deuterium, halogen, C6-C30 aryl or C5-C30 heteroaryl, wherein at least one is C12-C30 aryl or C12-C30 heteroaryl;
X1is carbon or nitrogen.
3. The phenanthroline compound according to claim 1, wherein R is1To R16Each independently selected from substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted anthryl, substituted or unsubstituted phenanthryl, substituted or unsubstituted pyrenyl, and substituted or unsubstituted pyridineA group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted benzimidazolyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted quinolyl group, a substituted or unsubstituted isoquinolyl group, a substituted or unsubstituted phenanthroline group, a substituted or unsubstituted naphthyridinyl group, or a combination thereof.
4. The phenanthroline compound according to claim 1, wherein the phenanthroline compound represented by formula 1-1 is represented by the following formula 2-1-formula 2-3:
Figure FDA0003540084620000021
wherein R is2—R16Each independently selected from substituted or unsubstituted hydrogen, deuterium, halogen, alkyl, C6-C30 aryl, and C5-C30 heteroaryl;
X1and X2Selected from carbon or nitrogen.
5. The phenanthroline compound of claim 2, wherein the phenanthroline compound is any one of:
Figure FDA0003540084620000031
Figure FDA0003540084620000041
Figure FDA0003540084620000051
Figure FDA0003540084620000061
6. an organic electroluminescent device comprising:
a first electrode;
a second electrode; and
an organic layer between the first electrode and the second electrode;
the organic layer comprises the phenanthroline compound of any one of claims 1-5.
7. The organic electroluminescent device according to claim 6, wherein at least one of the organic layers is a charge generation layer or an electron transport layer.
8. The organic electroluminescent device according to claim 7, wherein the charge generation layer is an n-type charge generation layer.
9. The organic electroluminescent device according to claim 8, wherein the n-type charge generation layer is composed of a metal or an organic material doped with n-type, wherein the metal is selected from Li, Na, K, Rb, Cs, Mg, Ca, Sr, Ba, La, Ce, Sm, Eu, Tb, Dy, or Yb.
10. An organic electroluminescent device comprising:
a first electrode;
a second electrode;
a first light-emitting portion of a first light-emitting layer located between the first electrode and the second electrode;
a second light emitting portion of a second light emitting layer located between the second electrode and the first light emitting portion; and
a first charge generation layer located between the first light-emitting portion and the second light-emitting portion;
at least one of the first luminescent moiety, the second luminescent moiety, or the first charge generation layer comprises an o-phenanthroline compound according to any one of claims 1-5.
11. Use of a phenanthroline compound according to any one of claims 1-5 for the manufacture of organic electroluminescent devices.
12. A display or lighting apparatus comprising the organic electroluminescent device according to claim 6 or 10.
CN202210229776.5A 2022-03-10 2022-03-10 Phenanthroline compound, organic electroluminescent device and display or lighting device Pending CN114478589A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210229776.5A CN114478589A (en) 2022-03-10 2022-03-10 Phenanthroline compound, organic electroluminescent device and display or lighting device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210229776.5A CN114478589A (en) 2022-03-10 2022-03-10 Phenanthroline compound, organic electroluminescent device and display or lighting device

Publications (1)

Publication Number Publication Date
CN114478589A true CN114478589A (en) 2022-05-13

Family

ID=81486390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210229776.5A Pending CN114478589A (en) 2022-03-10 2022-03-10 Phenanthroline compound, organic electroluminescent device and display or lighting device

Country Status (1)

Country Link
CN (1) CN114478589A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116948630A (en) * 2023-06-05 2023-10-27 宇瑞(上海)化学有限公司 OLED luminous composition and electroluminescent device comprising same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109180567A (en) * 2018-09-25 2019-01-11 武汉天马微电子有限公司 Nitrogen heterocyclic compound, display panel and display device
CN109384802A (en) * 2017-08-08 2019-02-26 三星显示有限公司 Heterocyclic compound and organic light emitting apparatus and electronic equipment including the heterocyclic compound
KR20190053354A (en) * 2017-11-10 2019-05-20 주식회사 진웅산업 Phenanthroline-anthracene compound and organic light emitting diode comprising the same
CN113651836A (en) * 2021-08-18 2021-11-16 清华大学 Organic compound and organic electroluminescent device containing same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109384802A (en) * 2017-08-08 2019-02-26 三星显示有限公司 Heterocyclic compound and organic light emitting apparatus and electronic equipment including the heterocyclic compound
KR20190053354A (en) * 2017-11-10 2019-05-20 주식회사 진웅산업 Phenanthroline-anthracene compound and organic light emitting diode comprising the same
CN109180567A (en) * 2018-09-25 2019-01-11 武汉天马微电子有限公司 Nitrogen heterocyclic compound, display panel and display device
CN113651836A (en) * 2021-08-18 2021-11-16 清华大学 Organic compound and organic electroluminescent device containing same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116948630A (en) * 2023-06-05 2023-10-27 宇瑞(上海)化学有限公司 OLED luminous composition and electroluminescent device comprising same
CN116948630B (en) * 2023-06-05 2024-04-16 宇瑞(上海)化学有限公司 OLED luminous composition and electroluminescent device comprising same

Similar Documents

Publication Publication Date Title
CN101855315B (en) New compound and organic light emitting device using the same
KR101719173B1 (en) Organic electroluminescent element
CN111253442B (en) Organic iridium metal complex, preparation method thereof and organic electroluminescent device
CN114315871B (en) Phenanthroline compound, organic electroluminescent device and display or lighting device
CN114874208B (en) Phenanthroline compound, organic electroluminescent device and display or lighting device
CN111699177A (en) Heterocyclic compound and organic light emitting device including the same
KR101558966B1 (en) Asymmetric ortho-Terphenyl Derivatives and Organic light emitting device Comprising the Same
CN112552270B (en) Organic electroluminescent compound and organic electroluminescent device
CN111116628A (en) Organic compound and organic electroluminescent device using same
CN113528123B (en) Host material and organic electroluminescent device comprising same
CN114478589A (en) Phenanthroline compound, organic electroluminescent device and display or lighting device
CN114573579B (en) Phenanthroline compound, organic electroluminescent device and display or lighting device
CN111747962B (en) Organic electroluminescent compound, preparation method thereof and organic electroluminescent device
CN115850302A (en) Phenanthroline compound, organic electroluminescent device and display or lighting device
CN113620951B (en) Phosphorescent compound, preparation method thereof and organic electroluminescent device
CN110922391A (en) Nitrogen-containing compound, electronic component, and electronic device
KR20200103380A (en) Phosphine oxide compound and organic light emitting element comprising the same
CN114621257B (en) Phenanthroline compound, organic electroluminescent device and display or lighting device
CN113248519A (en) Organic compound and organic light-emitting device using same
CN109096291B (en) Organic photoelectric device containing disubstituted indolo heterocyclic compound and application thereof
CN113620858A (en) Organic electroluminescent compound and preparation method and application thereof
CN112079833A (en) Organic electroluminescent compound and preparation method and application thereof
CN113683627B (en) Host material and organic electroluminescent device comprising same
KR20190127622A (en) Novel organic compounds for organic light-emitting diode and organic light-emitting diode including the same
CN116120345A (en) Phenanthroline derivative, organic electroluminescent device and display or lighting device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination